Activation of the spi-1/PU.1 proto-oncogene and loss of p53 function are genetic alterations associated with the emergence of Friend malignant erythroleukemic cells. To address the role of p53 during erythroleukemogenesis, spi-1 transgenic mice (spi-1-Tg) which develop erythroleukemia were bred with p53-de®cient mice. Three classes of spi-1 transgenic mice diering in their p53 functional status (p53
Introduction
The murine Friend acute erythroleukemia caused by the retrovirus SFFV (Spleen Focus Forming Virus) is a multistage neoplasm suitable to study the sequential activation or inactivation of genes involved in the progression of proerythroblastic cells towards malignancy (Ben-David and Bernstein, 1991) . The early step of the Friend disease is characterized by a deregulated proliferation and dierentiation of proerythroblasts exhibiting hypersensitivity or independence for erythropoietin (Epo). This initial phase is induced by the gp55 glycoprotein encoded by the SFFV env gene which constitutively activates the Epo receptor (Aizawa et al., 1990; Li et al., 1990) . During a later stage, a clonal population of proerythroblasts emerge that are arrested in their dierentiation and tumorigenic in vivo (Mager et al., 1981; Wendling et al., 1981) . In these tumor cells, two recurrent genetic alterations have been identi®ed: a transcriptional dysregulation of the spi-1 gene by a SFFV insertional mutagenesis (MoreauGachelin et al., 1988) and the extinction of the p53 gene because of allelic deletions or punctual mutations (Ben-David et al., 1988; Mowat et al., 1985; Munroe et al., 1990) .
Spi-1/PU.1 is a master gene in the development of B lymphoid, monocytic and neutrophilic lineages. Its activity is likely mediated through its transcriptional activator function and involves a large set of target genes and interacting proteins (for review see Oikawa et al., 1999) . Spi-1/PU.1 is not involved in the development of the erythroid cell lineage since erythropoiesis occurs normally in spi-1/PU.1 de®cient mice (McKercher et al., 1996; Scott et al., 1994) . However, the ectopic overexpression of spi-1/PU.1 in proerythroblasts leads to cell transformation. This has been demonstrated in avian erythroid progenitors infected by spi-1-transducing retroviruses (Tran Quang et al., 1997) as well as in transgenic mice overexpressing spi-1 in hematopoietic cells (MoreauGachelin et al., 1996) . Spi-1 transgenic mice develop a progressive erythroleukemia characterized by anemia and hepatosplenomegaly (HS1 stage) due to the proliferation of proerythroblastic cells arrested in their dierentiation process. At the onset of the disease, survival and proliferation of proerythroblasts remain under the control of Epo, as indicated either by the regression of splenomegaly observed after transfusions of red blood cells in diseased mice or by the strict Epo requirement of the spi-1 transgenic proerythroblasts to be established as permanent cell lines in vitro. In addition, these proerythroblasts are not malignant since they do not produce tumors when grafted into nude mice. Thus, the major eect of spi-1 overexpression in transgenic mice appears to be a blockage in the dierentiation process of the erythroid lineage. However, at a later stage during evolution of the disease (HS2 stage), malignant proerythroblasts characterized by autonomous growth in vitro and tumorigenicity in vivo are readily isolated. Such a late emergence of malignant proerythroblasts suggested the occurrence of other oncogenic alterations. Due to its recurrent alteration in Friend erythroleukemic cells (Ben-David and Bernstein, 1991; Mowat et al., 1985; Munroe et al., 1990) , mutation or deletion of the p53 gene appeared as potential determinants in the progression of this erythroleukemic process.
The main prevailing function of p53 is to contribute to the control of cell cycle arrest and cell death by apoptosis, two pathways that prevent the survival of cells with genomic abnormalities (for review see Levine, 1997) . In addition to its role in maintaining the integrity of the genome, many data argue for a role of p53 in the regulation of various survival and dierentiation processes, in particular during hematopoiesis. Overexpression of wild-type p53 can trigger the expression of dierentiation markers in L12 pre-B leukemic cells (Shaulsky et al., 1991) , in the K562 chronic myelogenous leukemic cells (Chylicki et al., 2000; Feinstein et al., 1992) or in the IW 32 erythroleukemic cells (Tang and Wang, 2000) . Hematopoietic progenitor cells derived from p53-de®cient mice exhibit a hypersensitivity to growth factors (Lin and Benchimol, 1995; Lotem and Sachs, 1993) . IL6, IL3 or Epo are able to prevent apoptosis induced by overexpression of wild-type p53 in myeloid (Gottlieb et al., 1994; Yonish-Rouach et al., 1991) or erythroid leukemic cells (Johnson et al., 1993) . Altogether, these data suggest that p53 may interfere with growth factors signaling pathways. However, these results were obtained with immortalized cell lines, most of them originating from tumors.
The spi-1 transgenic mouse model oers the opportunity to study in vivo the role of p53 in the proliferation of the proerythroblasts and to explore whether loss of p53 and overexpression of spi-1 synergize for the progression of the proerythroblast towards malignancy. In this study, we have examined the contribution of p53 in the spi-1-dependent erythroleukemic process by generating mutant mice that are de®cient in p53 in addition to being transgenic for spi-1. We show that germ-line deletion of p53 resulted in accelerated appearance and 100% penetrance of the spi-1-induced erythroleukemia. However, germ-line deletion of p53 was not sucient to induce tumorigenicity of spi-1-Tg erythroblasts.
Results

Generation of p53-deficient spi-1 transgenic mice
To explore whether p53 de®ciency cooperates with the spi-1 oncogene in erythroleukemia, spi-1 transgenic mice (spi-1-Tg) were crossed with p53 knockout mice (Jacks et al., 1994) . Three classes of spi-1 transgenic animals that diered in their p53 status (p53 +/+ , p53
and p53 7/7
) were generated. As described in Materials and methods, these animals were genetically dierent from the initial R36 spi-1-Tg line (Moreau-Gachelin et al., 1996) and were designated as R36 sv line. The p53 7/7 spi-1-Tg mice appeared normal at birth and developed in a manner indistinguishable from the p53 +/+ or p53 +/7 spi-1-Tg littermates.
Erythroleukemia in p53 +/+ spi-1 transgenic R36sv mice
We ®rst analysed the incidence, latency and progression of erythroleukemia in p53 +/+ spi-1-Tg mice with the R36sv genetic background. Among 131 mice analysed, 29% became diseased versus 47% in the R36 line (Moreau-Gachelin et al., 1996) . The mean time for disease appearance was not statistically modi®ed (average latency of 4.3+2.4 months in the R36sv line versus 3.6+1.5 months in the R36 line). Diseased mice were anemic (hematocrit: 26+5%) and presented a hepatosplenomegaly (spleen : 1.3+0.5 g, liver : 3.5+0.8 g). Spleens and livers were massively in®ltrated by a predominant population of immature proerythroblast-like cells. Nucleated cells in the peripheral blood were 10 ± 20-fold increased with a majority of late hemoglobinized polychromatophilic erythroblasts (Table 1) . When compared to blood smears from diseased R36 mice (Moreau-Gachelin et al., 1996) , these nucleated erythroid cells appeared generally more mature suggesting that the blockage in the erythroid dierentiation might occur at a later stage (Figure 1 ). Most probably, these discrepancies in the stage of the dierentiation arrest and the disease incidence are related to the genetic background. Epo was obligatory to support the survival and proliferation of these erythroblasts since a hematocrit elevation by repeated red blood cell transfusions was sucient to transiently cure the mice. Cells from enlarged spleens were able to establish in vitro permanent erythroid cell lines which remained strictly dependent upon Epo for both survival and proliferation. Upon subcutaneous transplantation into nude mice, cells from primary enlarged spleen (seven donors tested) were unable to produce tumors. As reported previously (MoreauGachelin et al., 1996) , spi-1 transgene transcriptional levels were elevated in the leukemic spleen cells (Figure 2A, lane 1) . Thus, when compared to the erythroleukemia characterized in the R36 line, R36sv spi-1-Tg mice developed a very similar pathology. Consequently, the role of p53 in the spi-1-induced erythroleukemic process was further analysed in the R36sv line.
Erythroleukemia in p53
+/7 spi-1 transgenic mice
As illustrated in Figure 4 , leukemia incidence was signi®cantly increased in hemizygote p53 +/7 spi-1-Tg mice (45%, 92/203) in comparison to p53 +/+ spi-1-Tg animals (29%, 38/131), but the mean latency for spleen outgrowth was similar (4.2+2.4 months). Diseased animals displayed the clinical characteristics described for the p53 +/+ spi-1-Tg mice. In particular, nucleated blood cells were mainly at the polychromatophilic and acidophilic stages (Table 1, Figure 1 ).
Cells from enlarged spleens at the appearance of splenomegaly (14 mice tested) were plated in liquid medium to examine their growth factor requirement. The tumorigenic potential of p53 +/7 spi-1-Tg proerythroblasts was determined by subcutaneous transplantation into nude mice. Four to 5 weeks after the graft, tumor nodules were evident in each one of the grafted hosts (14 donors tested). Thus, Epo independence and tumorigenicity appeared as two associated characteristics of the p53 +/7 spi-1-Tg erythroblasts. These results suggested that either a reduction in wildtype p53 dosage and/or an oncogenic mutation occurring in the residual p53 allele could account for the fully malignant phenotype of the proerythroblasts. We ®rst analysed p53 transcription in enlarged spleens, but we were unable to detect p53 transcripts by Northern blotting ( Figure 2A , lane 2). Next, the p53 gene structure was examined by Southern blotting in the spleens and the corresponding tail biopsies taken on 14-day-old mice. The unique wild-type p53 allele was lacking in all of the 14 enlarged spleens analysed (only ®ve of them are depicted in Figure 3 ) suggesting that a genomic deletion occurred. These results demonstrate that elimination of the normal p53 allele was a common event during in vivo tumorigenesis in the p53 +/7 spi-1 transgenic mice.
7/7 spi-1 transgenic mice Strikingly, all of the 68 born p53 7/7 spi-1-Tg animals died over a short period of 2.4+1.0 months (Figure 4 ) with clinical signs of erythroleukemia as those described above ( Figure 1 , Table 1 ).
The in vitro growth characteristics and in vivo tumorigenicity of cells from 26 enlarged spleens were examined as outlined above. Two types of in vitro cell ) from spi-1 transgenic mice of p53 +/+ (A, B, C); p53 +/7 (D, E, F) and p53 7/7 (G, H, I) genotypes. Cytocentrifuged cells were stained with benzidine and May-GruÈ nwald Giemsa (magni®cation, 1006). The predominant blastic cells in spleen and culture cells smears are basophilic erythroblasts. In blood smears, more mature polychromatophilic and acidophilic erythroblasts are obvious lines were derived: 13 were strictly dependent upon Epo for survival and proliferation while 13 did not require growth factors to proliferate. Whether cells were Epo-dependent or growth factor autonomous, they constituted a morphologically homogenous population of proerythroblast-like cells comprising a low percentage (less than 3%) of benzidine-positive cells. Their erythroid nature was con®rmed by Northern blot analysis of expression of Epo receptor and b globin ( Figure 2A , lanes 3 ± 5). Cells from leukemic spleens were also analysed for their tumorigenic potential by subcutaneous transplantation into nude mice. Of the 13 spleens from which Epo-dependent cell lines were derived, six failed to produce subcutaneous tumors while seven were tumorigenic. Of the 13 spleens from which autonomous cell lines were isolated, 11 produced tumors while two were not tumorigenic. Thus, in sharp contrast to p53
spi-1-Tg mice, no correlation between the ability of transformed erythroblasts to generate tumors in vivo and to grow autonomously in vitro were observed as illustrated in Figure 5 . These data suggest that growth factor independence and tumorigenicity might be determined by independent events.
Tumor clonality in p53
+/7 and p53
spi-1 transgenic mice
To study whether splenomegaly arose from the outgrowth of a clonal population of transformed erythro- Figure 2 Expression of spi-1, p53, erythroid markers (A) and p53 target genes (B) in p53 +/+ , p53 +/7 and p53 7/7 spi-1-Tg proerythroblasts. RNAs were isolated from p53 +/+ (lanes 1), p53 +/7 (lanes 2) and p53 7/7 (lanes 3) spi-1-Tg spleen tumors and from p53 7/7 either Epo-dependent (D) (lanes 4) or Epo-independent (I) (lanes 5) cell lines. RNAs were analysed by Northern blotting. A representative RNA sample was depicted for each type of tissues and cell lines. Total RNAs (20 mg) were used to analyse the expression of spi-1, p53, EpoR and bglobin genes. Poly(A) + RNAs (2 mg) were used to analyse expression of mdm2, Gadd45, Bax and p21
waf/Cip1 genes. The same blot was subsequently stripped and hybridized with the indicated probes. Hybridization with the GAPDH probe was used as control for RNA loading. (C) p21 waf/Cip1 RNA expression in Epo-independent cell lines (c) grown with (+) to without (7) Epo. Numbers refer to the diseased mice number blasts, we used the insertional mutagenesis of the replicative Friend murine leukemia virus (F-MuLV) as a molecular marker. Newborn p53 +/+ , p53 +/7 and p53 7/7 spi-1-Tg mice were infected with the B3 strain of F-MuLV (Sitbon et al., 1986) . B3 is a low virulent strain that induces leukemias after a latency period exceeding 8 months. When B3-infected animals developed the transgenic disease, proviral integration sites were analysed in DNAs from enlarged spleens. DNAs were digested with an endonuclease that generates a single cleavage inside the proviral genome and then analysed on Southern blots hybridized with a F-MuLV env probe. Discrete bands of identical intensity when compared to the ecotropic endogenous locus, were detectable in spleen tissues from all animals whatever their p53 genotype (Figure 6 ). This demonstrated that splenomegaly originated from the clonal proliferation of transformed proerythroblasts. From these data, we conclude that the in vivo erythroleukemic process in spi-1-Tg mice is related to a cell selection process in p53 7/7 as well as in p53 +/7 and p53 +/+ mice. The origin of this cell selection process remains unknown.
p53 target genes p53 is a transcription factor and most of its eects on cell cycle arrest and apoptosis are related to its ability to bind DNA in a sequence-speci®c manner Kern et al., 1991) . We sought to examine the transcription level of a set of downstream targets of p53 by Northern blotting of mRNAs from erythroleukemic spleen as well as in Epo-dependent and Epoindependent cell lines. Figure 2B exhibits a typical expression pattern of these genes in each one of the spleen or cell types. No change in the transcription pattern of genes encoding Bax, a mediator of cell death (Miyashita and Reed, 1995) , Gadd45 involved in DNA repair and replication (Kastan et al., 1992) or mdm2, a negative regulator of p53 (Barak et al., 1993; Wu et al., 1993) was found in spi-1-Tg proerythroblasts isolated from tissues or in vitro cell lines as a function of their p53 genotype ( Figure 2B ). Thus the basal expression level of these genes does not depend on p53.
We also analysed transcription levels of the p21 Cip1/Waf1 gene which encodes an inhibitor of the cyclin-dependent kinases (el-Deiry et al., 1993). p21
Cip1/Waf1 transcripts could be detected in all erythroleukemic spleens irrespective of their p53 genotype as well as in all Epo-dependent cell lines ( Figure 2B ). In contrast, p21
Cip1/Waf1 mRNAs were not detected in the Epo-independent cell lines. The discrepancy in p21 transcription between a spleen and its corresponding Epo-independent cell line was reproducibly observed (®ve pairs studied). However, addition of Epo to the culture medium of these ®ve Epo-independent cell lines was sucient to trigger p21 Cip1/Waf1 mRNA transcription ( Figure 2C) . We conclude that, in the spi-1-Tg proerythroblasts, the control of p21 Cip1/Waf1 basal transcription does not involve p53 but is under Epo control.
Discussion
We have previously reported that spi-1 transgenic (spi-1-Tg) mice develop an erythroleukemia evolving as a multistep process (Moreau-Gachelin et al., 1996) . Within 4 months after birth, mice become anemic with spleen massively invaded by erythroid precursor cells dependent upon Epo for their proliferation, and unable to produce tumors when transplanted into secondary hosts (HS1 stage). The hallmark of this premalignant stage is a maturation arrest at the proerythroblast level leading to a severe anemia. In a second stage, fully malignant proerythroblasts emerge that are independent of growth factors for in vitro proliferation and tumorigenic in vivo (HS2 stage). Because inactivation of the p53 gene occurs in the context of immortalization of Friend virus-transformed erythroblasts (Ben- Figure 4 Survival of spi-1 transgenic mice of p53 +/+ (circles), p53 +/7 (triangles) and p53 7/7 (squares) genotypes. No dierences in male or female survival could be observed Figure 3 Analysis of the p53 genotype in spi-1-Tg tumors: The structure of the p53 gene was determined in tails (t) and enlarged spleen (s) of individual p53 +/+ and p53 +/7 mice by Southern blotting. Ten micrograms of genomic DNAs were digested with Stu1, transferred to nitrocellulose and hybridized with a p53 cDNA probe. The numbers identify the tail and spleen donors from one diseased mouse. The wild-type (wt) and mutant (m) alleles of p53 are indicated as well as the pseudogene (C) David et al., 1988; Munroe et al., 1990; Wong et al., 1999) , the contribution of p53 in the spi-1-induced erythroleukemia was to be considered. We previously determined that p53 was not altered in HS1 spleens revealing that p53 alteration did not contribute to the arrest of the erythroid dierentiation in the spi-1-Tg mice (Barnache et al., 1998) . In the present study, we approached the role of p53 during the in vivo progression of the erythroleukemic process by generating spi-1-Tg animals with a p53 7/7 genetic background. The most striking ®nding of this study is the demonstration that the germ-line deletion of p53 was not sucient to confer Epo-independence and tumorigenicity to the transformed proerythroblasts. However, the absence of p53 resulted in a 100% incidence and an accelerated rate of leukemia appearance.
Several studies have demonstrated that p53 knockout mice are predisposed to develop a majority of sarcoma and thymoma, and that the genetic background of the mice directly in¯uences the spectrum of tumors Purdie et al., 1994) . In addition, the cooperation of oncogenes, such as myc (Blyth et al., 1995) or ras (Elson et al., 1995) with a loss in p53 function has been shown to depend on the cellular context (Elson et al., 1995) . Nevertheless, only erythroleukemias were observed in diseased spi-1-Tg mice with a dierent genetic background (R36sv and R36 lines) and the p53 status (p53
7/7
) did not in¯uence the nature of transformed cells. These data establish that overexpression of spi-1 Figure 5 Illustration of the various phenotypic characteristics of the proerythroblasts isolated from diseased p53 +/+ , p53 +/7 and p53 7/7 spi-1-Tg mice. Proerythroblasts from spleens could be established as permanent cell lines in vitro either in the presence of Epo (EpoD) or in the absence of Epo (EpoI). They were able (T+) or not (T7) to produce tumors when grafted in nude mice. The per cent of animals in which various proerythroblast phenotypes were characterized, is indicated. HS1 and HS2 indicate the two stages in the erythroleukemic process. The syringe symbols represent the repeated red blood cell transfusions required to observe the HS2 stage +/7 and p53 7/7 spi-1-Tg mice infected at birth with F-MuLV. Ten micrograms of genomic DNAs were digested with EcoR1, transferred to nitrocellulose and hybridized with a F-MuLV speci®c env probe. Proviral insertions are characterized by additional bands above the ubiquitous band (*) which represents endogenous ecotropic env sequences of the murine genome. s2 to s9 corresponds to the spleen identi®cation number of a diseased animal. Tail from an uninfected p53 +/+ mouse was used as control (C) is the key determinant for the erythroblastic phenotype of tumors arising in these transgenic mice. In hemizygous p53 +/7 spi-1-Tg mice, the latency for erythroleukemia appearance was comparable to that of wild-type p53 spi-1-Tg animals. However, proerythroblasts taken at the onset of spleen enlargement were aggressively tumorigenic in vivo and gave rise to Epoindependent cell lines in culture revealing that tumor progression was accelerated. Interestingly, the remaining wild-type p53 allele was deleted in these tumors as described for numerous animal tumor models and human cancers Honda et al., 2000; Hundley et al., 1997; Jacks et al., 1994; Purdie et al., 1994; Wong et al., 1999) . Isolation of highly tumorigenic p53
7/7 spi-1-Tg proerythroblasts in mice with a p53 +/7 genetic background suggests that loss of the single p53 allele is involved in the accelerated erythroleukemic process and may contribute to the tumorigenic phenotype of the proerythroblast. Indeed, Epo mitogenic signals in anemic spi-1-Tg mice predispose proerythroblasts to accumulate mutations. A germinal p53 de®ciency might therefore create conditions of genome instability being in favor of genetic alterations able to confer both growth autonomy and tumorigenicity to the proerythroblast.
A contrasting pattern was seen in p53 7/7 spi-1-Tg animals. Mice succumbed with a signi®cantly shorter latency than the p53 +/+ or p53 +/7 spi-1-Tg littermates and the penetrance of the disease was total. At ®rst, we hypothesized that the accelerated onset and full incidence of erythroleukemia in p53 7/7 spi-1-Tg mice could be the consequence of an earlier transgene expression in embryos. Indeed, the transgene transcription is driven by the SFFV LTR and p53 is known to be active during development (Komarova et al., 1997) and to repress some transcriptional promoters (Mack et al., 1993) and viral enhancers (Mori et al., 1997) . However no spi-1 transgene transcripts could be detected in fetal livers or embryo bodies when examined at 15 days of gestation in 27 embryos (p53 +/7 =8, p53 7/7 =8 and p53 +/+ =11) obtained from four dierent intercrosses (data not shown). Thus the accelerated onset and full incidence of erythroleukemia in p53 7/7 spi-1-Tg mice are not related to a transgene transcription occurring at an early developmental stage. Second, because wild-type p53 regulates cell cycle arrest and apoptosis (for reviews see Gottlieb and Oren, 1996; Levine, 1997; May and May, 1999) , we compared both the number of cells in the S phase of the cell cycle by labeling with PCNA proliferation marker and the number of apoptotic nuclei by TUNEL assay in histological sections from p53 +/+ and p53 7/7 leukemic spleens. No signi®cant dierences were seen between the two groups (data not shown). It remains however conceivable that the detection of subtle modi®cations might be impeded since, in these anemic animals, spleen erythroleukemic cells are continuously stimulated by the elevated levels of endogenous Epo. Furthermore, no alterations were detectable in the transcriptional regulation of some p53 target genes involved in the control of either cell cycle or cell death.
Unexpectedly with regard to the high rate of cell proliferation, the cell cycle inhibitor p21 Cip1/Waf1 gene was found to be expressed in all p53 7/7 erythroleukemic spleens and Epo-dependent cell lines. In autonomous cell lines, p21
Cip1/Waf1 transcripts were not detected unless Epo was added to the culture medium. These data demonstrate that p21
Cip1/Waf1 is transcriptionally regulated by Epo through a p53-independent mechanism in the spi-1-Tg proerythroblasts, its expression being an eect rather than a cause thereof. Induction of p21 transcription by Epo has been reported during dierentiation of human erythroid progenitor cells (Panzenbock et al., 1998) and Epoinduced dierentiation of primary erythroblasts isolated from the spleens of mice infected with the anemia-strain of Friend virus (FVA) (Hsieh et al., 2000; Kelley et al., 1998) . Morever, in FVA-infected erythroblasts induced to dierentiate, p53 markedly enhanced p21
Cip1/Waf1 mRNA expression. Thus in proerythroblasts, the p53-dependent up-regulation of p21
Cip1/Waf1 and its role in cell cycle arrest might be restricted to the Epo-induced dierentiation. Finally, no evident biological and molecular alterations may account for the accelerated progression of the erythroleukemic process in p53-de®cient spi-1-Tg mice.
The phenotypical characterization of the leukemic erythroblasts isolated from p53 7/7 mice revealed an unpredictable and complex pattern ( Figure 5 ). Indeed, 50% of the erythroleukemic spleen cells gave rise to cell lines that died after Epo deprivation whereas the other half generated Epo-independent cell lines. This reveals that p53-independent pathways participate in the Epo-controlled proerythroblast survival and agrees with the normal erythropoiesis that develops in p53-de®cient mice Jacks et al., 1994) . Moreover, half the spleen cells that generated the Epo-dependent cell lines were able to induce tumors in vivo. Thus growth factor autonomy and tumorigenicity in the proerythroblast results from independent genetic events. Highly malignant proerythroblasts which are both Epo-independent and tumorigenic were isolated from only 42% of the p53 7/7 diseased mice. The delayed appearance of the same highly malignant proerythroblasts in the p53 +/7 spi-1-Tg mice as compared to the p53 7/7 spi-1-Tg mice re¯ects most probably the longer time to select oncogenic mutations when a single p53 allele is remaining. But, the most surprising ®nding of this study is that splenic proerythroblasts in 23% of the animals were unable to generate tumors in addition to remaining Epo-dependent. Thus, the loss of p53 function is not sucient to render spi-1-Tg proerythroblasts tumorigenic and Epo-independent.
The heterogeneous phenotype of the p53 7/7 spi-1-Tg proerythroblasts indicates that several oncogenic events are required to reach full malignancy. In that way, spi-1 overexpression appears more as an early oncogenic lesion leading to erythroid dierentiation arrest and p53 loss as a permissive event for the illegitimate survival of proerythroblasts harboring genetic aberrations. The nature of the oncogenes or antioncogenes that might cooperate with spi-1 to confer full malignancy remains to be elucidated. The p53-de®cient spi-1 transgenic line appears as an in vivo model to obtain mechanistic insights about the oncogenic determinants involved in erythroleukemogenesis.
Materials and methods
Mice
The p53-de®cient mice carrying a deletion in the p53 gene (Jacks et al., 1994) were obtained from the CSAL-CNRS (OrleÂ ans-France). The spi-1 transgenic mice (Moreau-Gachelin et al., 1996) have been described previously. Hemizygous p53 +/7 spi-1-transgenic mice (spi-1-Tg) were produced by mating spi-1-Tg females (R36 line with a B6D26DBA2/J genetic background) and p53 7/7 males (C57B166129/sv genetic background). Homozygous p53 mutants (p53 7/7 spi-1-Tg) were obtained by backcrossing F1 females with C57B166129/sv p53 7/7 males and then intercrossing the ospring. As all these mice were of mixed C57B1/6, 129/sv and DBA2/J genetic background, we also derived controls spi-1-Tg mice with unmutated p53 alleles on the C57B166DBA2/J6129/sv genetic background by backcrossing the F1 animals with C57B166129/sv animals carrying wild-type p53 alleles (referred as R36sv line). Genotype of ospring was determined by Southern blotting of tail biopsy DNAs as described previously (Moreau-Gachelin et al., 1996) . Mouse spleen size was determined by weekly palpation. Animals were euthanized when spleen enlargement was around 1 g.
Derivation of permanent cell lines
Cell suspensions (10 6 cells/ml) from enlarged spleens were seeded in tissue culture¯asks in alpha modi®ed Eagle's medium (GIBCO, Paisley, UK) supplemented with 10% heatinactivated fetal bovine serum (GIBCO), 2 mM L-glutamine, 100 U/ml streptomycin, 100 U/ml penicillin, and 2 U/ml recombinant human Epo generously gifted by Cilag (Levallois-Perret, France) or no Epo. After 3 to 4 days in culture, cells were transferred into fresh culture medium with or without Epo. When cell density in suspension reached around 10 6 viable cells/ml, cells were passaged twice a week at a concentration of 2610 5 cells/ml.
Tumorigenicity of erythroleukemic spleen cells
Cells from enlarged spleens were dispersed in alpha modi®ed eagle's medium containing 2% fetal bovine serum. Cells (5610 6 cells /250 ml) were subcutaneously injected into 8 ± 10-week-old female nude mice (®ve recipient mice per assay). Tumor nodules were visible 3 ± 4 weeks after the graft when tumor mass reached a 0.5 cm diameter.
Retroviral infection of newborn mice
Batch of the B3 stock of F-MuLV used for in vivo infection contained 2610 6 focus-inducing units per ml. Newborn mice (less than 24 h old) were infected by intraperitoneal injection of 100 ml of supernatant as previously described (Barnache et al., 1998) .
Cytological examination
Peripheral blood was drawn from the retro-orbital sinus in heparinized microhematocrit tubes. Blood cells and cell suspensions from enlarged spleens (10 6 cells per ml) were diluted in culture medium and smears were prepared with a cytospin. Cells in culture were adjusted at 10 6 cells per ml and used to prepare cytocentrifuged smears. Smears were stained with benzidine and counterstained with May-GruÈ nwaldGiemsa.
RNA hybridization analysis
Total cellular RNAs were extracted from tissues homogenized in 4 M guanidinium thiocyanate solution as described by Chomczynski and Sacchi (1987) . Twenty mg of total RNAs or two mg of polyA + RNAs were separated by electrophoresis on 1% agarose-formaldehyde containing gels, transferred onto GeneScreen nylon membranes, hybridized with cDNA probes labeled with a 32 P-dCTP by using random-primed labeling kit (Amersham, UK). Hybridization of the ®lter and washing procedures were described previously (Moreau-Gachelin et al., 1996) . Sample loading were controlled by hybridization with a GAPDH probe (Fort et al., 1985) . Northern blots were hybridized with cDNA probes representative of p53 (Eliyahu et al., 1988) , spi-1 (Moreau-Gachelin et al., 1989), Epo-R (Lacombe et al., 1991) and mGATA-1 (Tsai et al., 1989) . The cDNAs probes corresponding to the murine Bax, Gadd45, mdm2 and p21
Cip1/Waf1 genes were cloned by RT-PCR from 745A Friend cells.
DNA hybridization analysis
High molecular weight DNAs were prepared from mouse tissues, digested with the indicated restriction enzymes, subjected to electrophoresis on 0.8% agarose gel migration and transferred to nitrocellulose. The blots were hybridized with the ecotropic F-MuLV viral env probe (MoreauGachelin et al., 1983 ) and washed as previously described (Moreau-Gachelin et al., 1988) .
